Lara Sullivan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lara Sullivan
Lara Sullivan was last confirmed as CEO and Board Member at Pyxis Oncology, Inc. (PYXS) in a filing dated April 29, 2025. The proxy statement of Pyxis Oncology, Inc. reports total compensation of $1,671,545 for Lara Sullivan in fiscal 2025, including a base salary of $646,875. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2019-01-01–2025-04-29
Last confirmed by a filing; no departure on record
-
Start not stated–2025-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pyxis Oncology, Inc. (PYXS) | Former President, Chief Executive Officer and Chief Medical Officer | $646,875 | $1,671,545 |
| 2024 | Pyxis Oncology, Inc. (PYXS) | President, Chief Executive Officer and Chief Medical Officer | $625,000 | $7,072,943 |
| 2023 | Pyxis Oncology, Inc. (PYXS) | President, Chief Executive Officer and Chief Medical Officer | $625,000 | $4,442,501 |
| 2022 | Pyxis Oncology, Inc. (PYXS) | President and Chief Executive Officer | $565,000 | $5,027,073 |
| 2021 | Pyxis Oncology, Inc. (PYXS) | M.D., President and Chief Executive Officer | $565,000 | $17,268,336 |
| 2020 | Pyxis Oncology, Inc. (PYXS) | M.D., Chief Executive Officer | $375,000 | $555,000 |
Recent activity
No call appearances or filed executive changes recorded yet.